Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

Learn from the experts about current and emerging immuno-oncology biomarkers to guide selection of optimal cancer treatment across tumor types. Participate in the interactive CCO Webinar or watch the on-demand Webcast and download the slides. Listen to a podcast for answers to FAQs asked during the live Webinar.

Share

Program Content

Activities

IO Biomarkers Across Tumor Types
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2020

Expires: August 23, 2021

Activities

IO Biomarkers: Q&A Session
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2020

Expires: August 09, 2021

Activities

<i>EP</i>: Biomarkers for IO Therapy
ExpressPoints: Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2020

Expires: July 14, 2021

IO Biomarkers: MSI/MMR for GI Cancers
Integrating MSI/MMR Testing for GI Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2020

Expires: July 08, 2021

IO Biomarkers: Focus on GU Cancers
Focus on GU Cancers: Current Clinical Experience With PD-1/PD-L1 Immune Checkpoint Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2020

Expires: July 08, 2021

IO Biomarkers: Lung Cancer
Overview of Biomarker-Selected Immune Checkpoint Blockade in Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2020

Expires: July 08, 2021

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck Sharp & Dohme Corp.